Get started
Author

Francesca Trave

Observed names: F. Trave, Trave, Francesca
OpenAlex ID: A5026017995
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience
2018 · Matteo Bassetti, Nadia Castaldo, et al. · International Journal of Antimicrobial Agents · 162
PDF
Candidemia in the elderly: What does it change?
2017 · Francesco Barchiesi, Elena Orsetti, et al. · PLoS ONE · 80
PDF
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
2020 · Matteo Bassetti, Antonio Vena, et al. · Open Forum Infectious Diseases · 69
PDF
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa
2020 · Antonio Vena, Daniele Roberto Giacobbe, et al. · Clinical Infectious Diseases · 40
Circulating lymphocyte subsets as promising biomarkers to identify septic patients at higher risk of unfavorable outcome
2021 · Ennio Polilli, Jessica Elisabetta Esposito, et al. · BMC Infectious Diseases · 24
PDF
Prevalence and Predictors of Low Bone Mineral Density and Fragility Fractures Among HIV-Infected Patients at One Italian Center After Universal DXA Screening: Sensitivity and Specificity of Current Guidelines on Bone Mineral Density Management
2015 · Elena Mazzotta, Tamara Ursini, et al. · AIDS Patient Care and STDs · 21
Characterisation of candidemia in patients with recent surgery: A 7‐year experience
2019 · Elena Orsetti, Lucia Brescini, et al. · Mycoses · 13
Safety and Efficacy of Dalbavancin in Real Life: Retrospective Analysis of a Large Monocentric Case Series of Patients Treated for Skin/Soft Tissue and Other Difficult-to-Treat Infections
2024 · Giustino Parruti, Ennio Polilli, et al. · Antibiotics · 7
Central venous catheter unrelated candidemia influences the outcome of infection in patients with solid tumors
2019 · Elena Orsetti, Lucia Brescini, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 5
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice
2014 · Valeria Cento, Monica Tontodonati, et al. · Digestive and Liver Disease · 4
PDF
May some HCV genotype 1 patients still benefit from dual therapy? The role of very early HCV kinetics.
2015 · Monica Tontodonati, Valeria Cento, et al. · PubMed · 1
PDF
12 Hcv Kinetics and Quasispecies Evolution Within the First Hours of Telaprevir-based Triple Therapy in Previously Treated Hcv-patients
2013 · V. Cento, F. De Luca, et al. · Journal of Hepatology · 1
Additional file 1 of Circulating lymphocyte subsets as promising biomarkers to identify septic patients at higher risk of unfavorable outcome
2021 · Polilli, Ennio, Esposito, Jessica Elisabetta, et al. · Figshare
Works count: 15
Citation count: 466
H-index: 8
I10-index: 8
Year
Topic
Type